Get started
Author

Coline Couillault

Observed names: Coline A Couillault, Coline A. Couillault, Coline Agnes Couillault, Couillault, Coline
Observed institutions: Lyon 1 Université, Centre National de la Recherche Scientifique, The University of Texas MD Anderson Cancer Center, Inserm, Université de Lyon, Columbia University Irving Medical Center, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Columbia University
ORCID: 0000-0001-8226-4613
Observed ORCID: 0000-0001-8226-4613
OpenAlex ID: A5064560062
Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus
2014 · Vanja Sisirak, Dipyaman Ganguly, et al. · The Journal of Experimental Medicine · 234
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
2022 · Rodney Cheng-En Hsieh, Sunil Krishnan, et al. · Science Immunology · 182
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
2020 · Margaux Hubert, Elisa Gobbini, et al. · Science Immunology · 147
PDF
Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration
2018 · Mathilde Small, Isabelle Treilleux, et al. · Acta Neuropathologica · 124
Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis
2019 · Aude Chefdeville, Isabelle Treilleux, et al. · Acta Neuropathologica Communications · 101
PDF
Mouse and Human Liver Contain Immunoglobulin A–Secreting Cells Originating From Peyer's Patches and Directed Against Intestinal Antigens
2016 · Ludovic Moro-Sibilot, Pascal Blanc, et al. · Gastroenterology · 88
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
2021 · Aparna Hegde, Priyamvada Jayaprakash, et al. · Clinical Cancer Research · 63
Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch repair-deficient colorectal cancer
2024 · Chad Tang, Genevieve P Hartley, et al. · BMJ Oncology · 14
PDF
Identification of Tertiary Lymphoid Structure-Associated Follicular Helper T Cells in Human Tumors and Tissues
2018 · Coline Couillault, Claire Germain, et al. · Methods in molecular biology · 12
592 ATR-mediated CD47 and PD-L1 upregulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
2021 · Rodney Cheng-En Hsieh, Sunil Krishnan, et al. · Regular and Young Investigator Award Abstracts · 9
PDF
Lefitolimod (TLR agonist) and ipilimumab in patients with advanced solid tumors: A phase I trial.
2023 · Mirella Nardo, Matthew Reilley, et al. · Journal of Clinical Oncology · 4
PDF
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial
2025 · Mirella Nardo, Mohamed A. Gouda, et al. · Journal of Immunotherapy and Precision Oncology · 3
291 Dual-specific antibodies blocking both PD-L1 and PD-L2 engagement of PD-1 restore anti-tumor immunity
2021 · Coline Couillault, Anupallavi Srinivasamani, et al. · Regular and Young Investigator Award Abstracts · 2
PDF
Abstract 7304: Cytotoxic PD-L1/PD-L2 dual-specific antibodies couple tumor stroma remodeling with checkpoint blockade to drive rejection of “cold” cancers
2025 · Ahmad Salameh, Coline Couillault, et al. · Cancer Research · 1
Abstract A70: IFN-III is selectively produced by cDC1 and predicts good clinical outcome in human breast cancer
2020 · Margaux Hubert, Coline Couillault, et al. · Cancer Immunology Research · 1
Specific genetic alterations and tumor immune contexture characterize ovarian tumors with paraneoplastic degeneration and anti-Yo antibodies
2017 · Mathilde Small, Isabelle Treilleux, et al. · Morphologie · 1
Supplementary Data from A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
2023 · Aparna Hegde, Priyamvada Jayaprakash, et al.
PDF
Data from A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
2023 · Aparna Hegde, Priyamvada Jayaprakash, et al.
Data from A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
2023 · Aparna Hegde, Priyamvada Jayaprakash, et al.
Supplementary Data from A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
2023 · Aparna Hegde, Priyamvada Jayaprakash, et al.
462 PD-L1/PD-L2 dual-specific cytotoxic antibodies augment survival and mediate tumor regression across immune "hot" and "cold" murine cancers
2022 · Coline Couillault, Anupallavi Srinivasamani, et al. · Regular and Young Investigator Award Abstracts
PDF
Complementary but distinct protective roles of breast tumor infiltrating IgG and IgA producing cells
2021 · Lounici, Yasmine, Couillault, Coline, et al. · HAL (Le Centre pour la Communication Scientifique Directe)
Modified bispecific antibodies blocking both PD-L1 and PD-L2 engagement of PD-1 show higher ADCC potential and in vivo anti-tumor response
2021 · Ashley Gelin, Coline Couillault, et al.
Heterogeneity and initiation mechanisms of the humoral immune response in breast and ovarian tumors
2019 · Couillault, Coline · theses.fr (ABES)
Hétérogénéité et mécanismes d’initiation de la réponse humorale dans les tumeurs du sein et de l’ovaire
2019 · Coline Couillault
Works count: 29
Citation count: 986
H-index: 9
I10-index: 9
Year
Topic
Type